×
About 620 results

ALLMedicine™ Follicular Thyroid Carcinoma Center

Research & Reviews  239 results

Nav1.6 promotes the progression of human follicular thyroid carcinoma cells via JAK-STA...
https://doi.org/10.1016/j.prp.2022.153984
Pathology, Research and Practice; Li H, Liu J et. al.

Jun 27th, 2022 - Follicular thyroid carcinoma (FTC) is one of the most common malignant tumors of the endocrine system. Recent studies have shown that voltage-gated sodium channels (VGSCs) affect the proliferation, migration, and invasion of tumor cells. However, ...

Highly Differentiated Follicular Thyroid Carcinoma Arising from Struma Ovarii at the Ti...
https://doi.org/10.1016/j.jmig.2022.06.009
Journal of Minimally Invasive Gynecology; Russo ML, Orlando MS et. al.

Jun 15th, 2022 - Highly Differentiated Follicular Thyroid Carcinoma Arising from Struma Ovarii at the Time of Hysterectomy.|2022|Russo ML,Orlando MS,King C,|

Papillary Thyroid Carcinoma
http://emedicine.medscape.com/article/282276-overview

Jun 14th, 2022 - Practice Essentials Papillary thyroid carcinoma (PTC) is the most common form of well-differentiated thyroid cancer, and the most common form of thyroid cancer to result from exposure to radiation. Papillary carcinoma appears as an irregular solid...

Papillary Thyroid Carcinoma
https://emedicine.medscape.com/article/282276-overview

Jun 14th, 2022 - Practice Essentials Papillary thyroid carcinoma (PTC) is the most common form of well-differentiated thyroid cancer, and the most common form of thyroid cancer to result from exposure to radiation. Papillary carcinoma appears as an irregular solid...

Follicular Thyroid Carcinoma
https://emedicine.medscape.com/article/278488-overview

Jun 14th, 2022 - Practice Essentials Follicular thyroid carcinoma (FTC) is the second most common cancer of the thyroid, after papillary carcinoma. Follicular and papillary thyroid cancers are considered to be differentiated thyroid cancers; together they make up ...

see more →

Clinicaltrials.gov  4 results

Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid Cancer
https://clinicaltrials.gov/ct2/show/NCT00537095

Nov 1st, 2021 - This is a parallel group, randomized, double blind, placebo controlled, multicentre study designed to assess whether vandetanib (ZD6474) confers an improvement in PFS as compared to placebo in subject with locally advanced or metastatic papillary ...

Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer
https://clinicaltrials.gov/ct2/show/NCT04948437

Sep 2nd, 2021 - Although, most thyroid cancers are clinically endocrine tumors of low malignancy, most patients usually receive radioactive iodine-131 treatment and thyroidectomy. Such patients are followed up with thyroid ultrasound and continuous serum thyroglo...

Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma
https://clinicaltrials.gov/ct2/show/NCT01813136

Aug 16th, 2019 - Total or near-total thyroidectomy is the primary treatment for differentiated thyroid carcinoma. Postoperatively, DTC are treated with radioiodine (131I) and thyroid stimulating hormone (TSH) suppressive levothyroxine therapy. But 5% to 20% of pat...

Postoperative Distress and Cosmetic Outcomes After Open Versus Robotic Thyroidectomy
https://clinicaltrials.gov/ct2/show/NCT01075269

Feb 25th, 2010 - Patient assessment A prospective study addressing perioperative outcomes and postoperative patient discomfort after thyroidectomy was commenced in April 2009 and is currently continuing. All patients were told about the operative techniques involv...

see more →

News  5 results

Fast Five Quiz: Thyroid Cancer Practice Essentials
https://reference.medscape.com/viewarticle/938275_6

Oct 1st, 2020 - Answer 5/5 Which of the following is recommended in the treatment of thyroid cancer, according to 2020 guidelines from the Japanese Association of Endocrine Surgeons (JAES)? Your peers chose: Total thyroidectomy is recommended for papillary thyroi...

My Strangest Case: The Man With a Heavy Tongue
https://reference.medscape.com/viewarticle/934944

Aug 4th, 2020 - Physical Examination and Workup A 63-year-old man was referred to us for recurrence of follicular thyroid carcinoma, with an anaplastic component, after an initial diagnosis of differentiated thyroid cancer 40 years prior. After that initial cance...

ATA risk stratification for DTC performs well in real-world cohort
https://www.mdedge.com/hematology-oncology/article/198839/endocrine-cancer/ata-risk-stratification-dtc-performs-well-real?channel=39313
Kari Oakes

Apr 13th, 2019 - NEW ORLEANS – The 2015 American Thyroid Association risk stratification system for patients with differentiated thyroid cancer performed well in a real-world cohort with a high proportion of high-risk patients, according to a study presented at th.

ATA risk stratification for DTC performs well in real-world cohort
https://www.mdedge.com/endocrinology/article/198839/endocrine-cancer/ata-risk-stratification-dtc-performs-well-real-world
Kari Oakes

Apr 13th, 2019 - NEW ORLEANS – The 2015 American Thyroid Association risk stratification system for patients with differentiated thyroid cancer performed well in a real-world cohort with a high proportion of high-risk patients, according to a study presented at th.

Is the Management of Thyroid Nodules and Differentiated Thyroid Cancer in Accordance With Recent Consensus Guidelines? - Results of a National Survey
https://www.staging.medscape.com/viewarticle/573815

Summary and Introduction Objective: To assess approaches to patients with a potentially malignant thyroid nodule and patients with differentiated thyroid carcinoma and compare them with the European Consensus and Guidelines by the American Thyroid...

see more →